Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Rosiglitazone on Adipose Tissue Angiogenesis
NCT01150981Phase 2Completed
- Sponsor
- University of Massachusetts
- Start
- Nov 2006
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rosiglitazone in insulin resistance (IR), metabolic syndrome, sponsored by University of Massachusetts. Started Nov 2006; status: completed.
02
Drugs
rosiglitazone
03
Conditions
insulin resistance (IR)metabolic syndrome
Beyond the preview
Go deeper on NCT01150981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01150981.